Cagrilintide (10mg) Description A single-component research material supplied for controlled research environments
Key highlights Medicare does not cover any medications for weight loss alone
GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas
While supplements are available, its essential to consult with a healthcare provider to determine safety and necessity, particularly since supplementation can interact with medications or underlying health conditions
Delivers powerful protective antioxidants